An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses

Immune checkpoint blockade (ICB) therapy involves the inhibition of immune checkpoint regulators which reverses their limitation of T cell anti-tumor responses and results in long-lasting tumor regression. However, poor clinical response or tumor relapse was observed in some patients receiving such...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chelsia Qiuxia, Choy, Fong Chan, Sanny, Arleen, Murakami, Takashi, Tan, Andy Hee-Meng, Lam, Kong-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856660/
https://www.ncbi.nlm.nih.gov/pubmed/36672244
http://dx.doi.org/10.3390/cells12020309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856660/
https://www.ncbi.nlm.nih.gov/pubmed/36672244
http://dx.doi.org/10.3390/cells12020309

Ejemplares similares